Patent details

EP1105111 Title: TRANSDERMALLY ADMINISTERED TOLTERODINE AS ANTI-MUSCARINIC AGENT FOR THE TREATMENT OF OVERACTIVE BLADDER

Basic Information

Publication number:
EP1105111
PCT Application Number:
PCT/SE/1999/001464
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP999465222
PCT Publication Number:
WO/2000/012070
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TRANSDERMALLY ADMINISTERED TOLTERODINE AS ANTI-MUSCARINIC AGENT FOR THE TREATMENT OF OVERACTIVE BLADDER
French Title of Invention:
TOLTERODINE ADMINISTREE PAR VOIE TRANSDERMIQUE EN TANT QU'AGENT ANTI-MUSCARINIQUE POUR TRAITER L'HYPERACTIVITE DE LA VESSIE
German Title of Invention:
TRANSDERMAL VERABREICHTES TOLTERODIN ALS ANTIMUSKARIN-WIRKSTOFF ZUR BEHANDLUNG DER HYPERAKTIVEN BLASE
SPC Number:

Dates

Filing date:
26/08/1999
Grant date:
20/08/2008
EP Publication Date:
20/08/2008
PCT Publication Date:
09/03/2000
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
13/06/2001
EP B1 Publication Date:
20/08/2008
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
26/08/2008
Expiration date:
26/08/2019
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
26/08/1999
 
 

Name:
Pfizer Health AB
Address:
-, 112 87 Stockholm, Sweden (SE)

Inventor

1

Name:
HOECK Ulla
Address:
Denmark (DK)

2

Name:
ORUP JACOBSEN Lene
Address:
Denmark (DK)

3

Name:
KRISTENSEN Helle
Address:
Denmark (DK)

4

Name:
KREILG RD Bo
Address:
Denmark (DK)

Priority

Priority Number:
9802864
Priority Date:
27/08/1998
Priority Country:
Sweden (SE)

Classification

Main IPC Class:
A61K 9/70;
Filing date Document type Number of pages